Generic placeholder image

Current Cancer Drug Targets

Author(s): Lianyong Liu, Fengying Wu, Xiaoying Zhang* and Xiangqi Li*

DOI: 10.2174/156800962503241107164731

DownloadDownload PDF Flyer Cite As
Corrigendum To: PIWIL1 Promotes Malignant Progression of Papillary Thyroid Carcinoma by Inducing EVA1A Expression

Page: [317 - 321] Pages: 5

  • * (Excluding Mailing and Handling)

Explore Articles
About Journal
For Authors
For Editors
For Reviewers

Abstract

In the article titled "PIWIL1 Promotes Malignant Progression of Papillary Thyroid Carcinoma by Inducing EVA1A Expression" published in Current Cancer Drug Targets, Volume 24, No. 2, 2024, pp. 192-203, the authors have identified errors in Figures 6 (E, F) and 7 (E, F). They request corrections to these figures to ensure accuracy in the representation of their findings.

We regret the error and apologize to readers.

The original article can be found online at: https://www.eurekaselect.com/article/132737

Erratum For:
PIWIL1 Promotes Malignant Progression of Papillary Thyroid Carcinoma by Inducing EVA1A Expression

[1]
Liu L, Wu F, Zhang X, Li X. PIWIL1 promotes malignant progression of papillary thyroid carcinoma by inducing EVA1A expression. Curr. Cancer. Drug Thr 2024; 24(2): 192-203. Available from: https://www.eurekaselect.com/article/132737.